TSMHT
DXCM icon

Thurston Springer Miller Herd & Titak’s DexCom DXCM Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-54
Closed -$4.71K – 761
2025
Q2 		$4.71K Hold
54
– – ﹤0.01% 1299
2025
Q1 		$3.69K Hold
54
– – ﹤0.01% 1347
2024
Q4 		$4.2K Hold
54
– – ﹤0.01% 1050
2024
Q3 		$3.62K Hold
54
– – ﹤0.01% 1255
2024
Q2 		$6.12K Buy
+54
New +$6.83K ﹤0.01% 1138

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's DXCM Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of DexCom (DXCM) in Q3 2025, closing a stake of 54 shares — an estimated $4.71K sold.

Thurston Springer Miller Herd & Titak first reported a position in DXCM in Q2 2024 and held it in 5 quarters. The position peaked at $6.12K in Q2 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 54 DexCom shares in Q3 2025, an estimated $4.71K.
  • Thurston Springer Miller Herd & Titak first reported a position in DexCom in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's DexCom position peaked at $6.12K in Q2 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.